Back

Evidence for CV event reduction with lower LDL-C.

29 August 2017 (13:10 - 13:30)
Organised by:
Congress Presentation Part of: PCSK9 inhibitors: the evidence-based story Atherosclerosis Open Access ESC Congress 2017

About the speaker

Photo
Professor Chris Packard

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Introduction - PCSK9 inhibitors: the evidence-based story.
Professor K. Ray (London, GB)
Video
Presentation thumbnail
The LDL-C paradigm.
Professor B. Ference (Cambridge, GB)
Video
Presentation thumbnail
Atherosclerosis regression and low LDL-C.
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
Panel discussion - PCSK9 inhibitors: the evidence-based story.
Professor K. Ray (London, GB)
Video
Presentation thumbnail
What questions remain unanswered?
Professor K. Ray (London, GB)
Video

Access the full session

Session thumbnail
PCSK9 inhibitors: the evidence-based story

The Event

Event poster

ESC Congress 2017

29 August 2017 13:10 CET
You may be interested in
thumbnail
Congress Presentation
How low should you go? Targets for LDL cholesterol in secondary prevention.
26 August 2022
thumbnail
Congress Presentation
Time course of LDL-C lowering after initiation of PCSK9 inhibition or bempedoic acid in atherosclerotic cardiovascular disease
20 March 2026
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024
thumbnail
Congress Presentation
The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources